Vitamin D2, Taken on a Weekly Basis, Prevents and Counteracts Vitamin D Deficiency
Scientists from BUSM (Boston University School of Medicine) discovered that 50,000 UI (International Units) of the D2 vitamin, taken on a weekly basis during a period of two months, has benefits in counteracting the deficiency of vitamin D. Quest Diagnostics which is United States most competitive provider of diagnostics services, knowledge and tests investigated the drug specimens utilized in the research.
D2 vitamin represents a food supplement for preventing and treating deficiency of vitamin D both for adults and children. If the patient desires to extend the duration of his or her D2 treatment for let`s say a period of just one week after the first decisive two months up to six years after them, the person just prevents the deficiency of vitamin D but with no adverse side-effects that could threaten his or her health.
The investigation undergone by researchers from Boston University School of Medicine is released on the Internet in the Archives of Internal Medicine journal. The research was led by Michael Holick who is the director of the Bone Healthcare Clinic Vitamin D, Skin and Bone Research Laboratory within the Boston University School of Medicine
Vitamin D is an important element in developing stronger bone mass due to the fact that it stimulated the organism to assimilate phosphorus and calcium from the food one eats or from exposure to the natural sunlight. The deficiency of vitamin D may trigger rickets in kids and the osteomalacia condition which represents a very painful illness in adults. This type of deficiency may also stimulate the appearance of osteoporosis and has also been associated with an enhanced predisposition of heart disease, autoimmune diseases, cancer, diabetes and viral illnesses comprising influenza.
The team of investigators focused on a sample of 86 patients. 41 of the people with vitamin D deficiency had to take for a period of two months 50,000 International Units of vitamin D2 on a weekly basis before commencing maintenance treatment. For this group, the average prior to treatment level of 25(OH)D (25-hydroxyvitamin D status) was of 19 ng/ml. After the two months of treatment, this initial level increased to 37 ng/ml. After this, this group of patients received a treatment of 50,000 International Units of vitamin D2 once every two weeks and recorded an average final level of 25-hydroxyvitamin D status of 47 ng/ml.
The remaining 45 people took just maintenance treatment comprising intakes of 50,000 International Units of vitamin D2 once every two weeks. They recorded a prior-to-treatment average level of 25-hydroxyvitamin D status of 27 ng/ml and afterwards, a final average of 47 ng/ml.
As Michael Holick who is director of the General Clinical Research Unit and teacher of medicine, physiology and biophysics within Boston University School of Medicine, also, states taking vitamin D2 brings a positive outcome because it increases the levels of 25-hydroxyvitamin D status if it is taken in physiologic and pharmacologic dosage. In treatments against deficiencies of vitamin D, if patients take lager doses of vitamin D2 they should stay calm because they have no adverse effects.
This investigation represents the first of its kind that proves just how effective the treatment with vitamin D2 in counteracting vitamin D deficiency, over the long-term and as a continuous practice.
